Physician profile
Brooke E Rogers
NPI 1154828416
$620.69
in general payments reported to CMS, 2019-2025
11 companies · $348 in 2025
The $348 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.75 · 2022: $35.76 · 2023: $97.27 · 2024: $63.67 · 2025: $348.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $509.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $509.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $153.04 | 2025 | |
| Exeltis, USA INC. | $97.27 | 2023 | Slynd |
| Janssen Pharmaceuticals, INC | $74.63 | 2021-2022 | |
| Sage Therapeutics, LLC | $72.69 | 2025 | Zurzuvae |
| Abbvie INC. | $63.67 | 2024 | |
| Xeris Pharmaceuticals, INC. | $45.46 | 2021-2025 | Gvoke Hypopen |
| Exact Sciences Corporation | $31.34 | 2025 | Cologuard Collection Kit |
| Astellas Pharma US INC | $31.17 | 2025 | Veozah |
| Supernus Pharmaceuticals, INC. | $23.42 | 2025 | Qelbree |
| Pfizer INC. | $15.29 | 2025 | |
| Lilly USA, LLC | $12.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.